# Phase 1–2 verification audit

**Audit date:** 16 July 2026
**Purpose:** Establish whether the previous phases have verified evidence sufficient to select a Phase 3 milestone.

## Repository evidence

- `frontend/` is an untracked Next.js App Router application with TypeScript, Tailwind CSS, a single static marketing page, shared `BrandLink`, `SectionHeading`, and `StoryCard` components, Figma-derived image files, and test configuration.
- The tracked Git diff contains only the `README.md` change. `AGENTS.md`, `docs/`, `frontend/`, and `work/` remain untracked. This audit does not make a source-control decision.
- `docs/phase-2-implementation-plan.md` does not exist. No Phase 2 implementation, API, database schema, migration, environment template, backend, or Phase 2 verification evidence exists.
- The original audit, gap analysis, roadmap, and design-system inventory pre-date `frontend/` and still describe the repository as having no frontend or runnable application.

## Verification commands run in this audit

From `frontend/`:

| Command | Result | Evidence |
| --- | --- | --- |
| `npm run format` and `npm run format:check` | Passed | All matched files use Prettier style. |
| `npm run lint` | Passed | No ESLint errors or warnings after the PostCSS export and test-image fixes. |
| `npm run typecheck` | Passed | `tsc --noEmit` completed successfully. |
| `npm test -- --reporter=verbose` | Passed | One marketing-shell unit test passed. |
| `npm run build` | Passed | Next.js 16.1.5 generated the static `/` route successfully. |
| `npm run test:e2e` | Passed after installing the required Chromium headless-shell runtime | `frontend/test-results/.last-run.json` reports `status: passed`. The existing test covers one 320px navigation/overflow smoke path. |

The Node process lock and dependency-corruption problems found during the audit were direct Phase 1 blockers. The resulting fixes were limited to generated dependency reinstallation, test discovery/path resolution, CSS side-effect typing, lint-safe configuration, and formatting; no product scope was expanded.

## Classification

| Earlier requirement | Classification | Repository evidence |
| --- | --- | --- |
| Next.js App Router, TypeScript, and Tailwind frontend foundation | Verified complete | `frontend/app`, TypeScript/Tailwind configuration, and passing build/type check. |
| Central identity tokens, Manrope, focus treatment, and reduced-motion baseline | Verified complete | `frontend/app/globals.css` and `frontend/app/layout.tsx`. |
| Official Figma R/pill mark and app-icon preview provenance | Complete with minor defect | Direct exported assets are in `frontend/public/`; `docs/brand-export-manifest.md` maps them to Figma node `6021:115`. A separately exportable horizontal wordmark and mascot remain unavailable and unused. |
| Header, hero, problem, solution, Snap → Understand → Act, preview shell | Verified complete | `frontend/app/page.tsx` and passing unit/build checks. |
| Preview-only privacy/health-data boundary | Verified complete | The page explicitly says it does not collect prescriptions, medication details, or health information; no form, client API call, fixture, or health-data input exists. |
| Responsive verification at 320, 375, 390, 430, 768, 1024, 1280, and 1440+ | Partially complete | One passing Playwright test verifies 320px overflow and first keyboard focus only. The remaining required widths have no evidence. |
| Keyboard, screen-reader, and reduced-motion browser verification | Partially complete | Semantic landmarks/labels and focus CSS are present; the Playwright test covers first keyboard focus. No complete keyboard flow, accessibility-tree, or reduced-motion browser evidence exists. |
| Chrome DevTools console/network/performance evidence | Unverifiable | No recorded DevTools session, screenshots, or network/console export exists. |
| Phase 1 status documentation | Partially complete | Plan, manifest, and README exist, but the four baseline status documents are stale and no verification-evidence document existed before this audit. |
| Phase 1 acceptance criterion that all checks and browser verification pass | Complete with minor defect | Format, lint, type check, unit, build, and basic Playwright now pass. The full responsive/DevTools/screenshot matrix remains incomplete. |
| Phase 2 plan | Not implemented | `docs/phase-2-implementation-plan.md` is absent. |
| Phase 2 marketing/conversion UI | Not implemented | No waitlist form, state model, product gallery, caregiver/privacy/FAQ/footer completion, or Phase 2 tests exist. |
| Phase 2 API, persistence, referral, rate-limit, security, and environment work | Not implemented | No backend, migrations, `.env.example`, API contract, or database files exist. |
| Phase 2 verification and documentation evidence | Not implemented | No Phase 2 code, plan, test results, or documentation updates exist. |

## Safety and repository hygiene findings

- **Passed:** No `.env` file, secrets, patient information, prescription image, email fixture, or production credential was found in the implementation files reviewed.
- **Passed:** The page does not claim medical advice, live prescription processing, or formal privacy/regulatory compliance.
- **Open risk:** The repository’s current docs and source-control state are contradictory: planning material and the app are untracked, while baseline status docs are stale.
- **Open risk:** Phase 1 uses an official R/pill mark and app-icon export, but the full approved asset set has not been exported; future work must not recreate the wordmark or mascot.

## Verdict and Phase 3 gate

**Phase 1 verdict: partially complete, with its direct build/test blockers fixed during this audit.** It is a static marketing foundation, not a complete conversion or product flow.

**Phase 2 verdict: not implemented.** There is no valid Phase 2 plan, code, evidence, or completed dependency for a Phase 3 vertical slice.

Selecting or implementing Phase 3 would therefore be a false phase progression and would skip the roadmap’s next high-priority user-facing and service work. The next coherent milestone remains a focused Phase 2 plan and implementation, followed by its verification and documentation updates. A Phase 3 plan must wait until that work exists and its acceptance criteria are evidenced.
